Polymyxin B Sulfate; Trimethoprim Sulfate

Drug Usage Statistics, United States, 2008 - 2018

Polymyxin B Sulfate; Trimethoprim Sulfate Summary for 2018

Estimated number of prescriptions in the United States 1,703,423
Top drug rank #268 ( 39)
Average total drug cost $12.01 (USD)
Average out-of-pocket cost $5.84 (USD)

Number of Prescriptions Over Time (2008 - 2018)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 775  186
2009 530  245
2010 702  172
2013 361 -
Year Rank Change
2014 385  24
2015 354  31
2016 339  15
2017 307  32
2018 268  39

Drug Cost Over Time (2008 - 2018)

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Related Drugs

Drug Name Total Prescriptions (2018)
Sulfamethoxazole; Trimethoprim 8,448,279
Polymyxin B Sulfate; Trimethoprim Sulfate (this drug) 1,703,424
Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate 1,261,713
Trimethoprim 96,945
Neomycin; Polymyxin B; Hydrocortisone 10,381

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Polytrim
  • Trimethoprim Sulfate And Polymyxin B Sulfate
Generic Drug Synonyms and Salts
  • Trimethoprim Sulfate; Polymyxin B Sulfate
  • Polymyxin B Sulfate; Trimethoprim Sulfate

FDA Approval Information

Established Pharmacologic Class (EPC): Polymyxin-class Antibacterial, Dihydrofolate Reductase Inhibitor Antibacterial
Initial FDA approval date: 10/20/1988
First FDA applicant: Rx
First dosage form: Solution/Drops (ophthalmic)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.1. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

 
©2021 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jan 18, 2021
Back to Top
Top